Related Experiment Video
Updated: Jul 18, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
[Secondary prevention of stroke]
1Neurologische Klinik der Ruprecht-Karls-Universität, Im Neuenheimer Feld 400, 69120 Heidelberg. Peter_Ringleb@med.uni-heidelberg.de
Patients experiencing transient ischemic attack (TIA) or ischemic stroke (IS) face high recurrence risks. This study presents a model to identify individuals who benefit most from specific antiplatelet therapies for secondary stroke prevention.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Context:
- Transient ischemic attack (TIA) and ischemic stroke (IS) patients have a significant risk of recurrence.
- Secondary prevention strategies are crucial for mitigating further strokes and cardiac events.
Purpose:
- To introduce a predictive model for identifying TIA/IS patients who benefit from specific antiplatelet therapies.
- To guide the selection of optimal secondary stroke prevention regimens.
Summary:
- Antiplatelet therapies, including acetylsalicylic acid (ASA), clopidogrel, and the combination of ASA plus slow-release dipyridamole, are effective in reducing secondary vascular events in TIA/IS patients.
- The study presents a novel prediction model to personalize antiplatelet therapy selection.
Impact:
- Enables tailored secondary stroke prevention strategies, potentially improving patient outcomes.
- Aims to optimize the use of antiplatelet medications for high-risk individuals, reducing healthcare burden.
Related Concept Videos
Atherosclerosis IV: Nursing Management
Preventive Healthcare Services
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Coronary Artery Disease IV: Preventive Measures
Ischemic Stroke l: Introduction
Atherosclerosis III: Management